000005706 000__ 01475cam\a22003735i\4500
000005706 001__ 5706
000005706 003__ SzGeWIPO
000005706 005__ 20240708160540.0
000005706 008__ 930327s1993\\\\enk\\\\\r\\\\u000\0\fre\d
000005706 035__ $$a(wipo)(CD )$33688
000005706 035__ $$a(OCoLC)1159942878
000005706 040__ $$aSzGeWIPO$$beng$$erda$$cSzGeWIPO$$dCaBNVSL
000005706 043__ $$an-cn---
000005706 084__ $$a72$$qGB
000005706 1001_ $$aDeeth, Douglas N.,$$eauthor.
000005706 24510 $$aCanada's new patent reforms hit generic drugmakers /$$cDouglas N. Deeth.
000005706 264_1 $$aLondon [England] :$$bEuromoney Institutional Investor PLC,$$c1993.
000005706 300__ $$a1 volume ([2] pages) ;$$c[28] cm.
000005706 336__ $$atext$$btxt$$2rdacontent
000005706 337__ $$aunmediated$$bn$$2rdamedia
000005706 338__ $$avolume$$bnc$$2rdacarrier
000005706 4901_ $$aManaging Intellectual Property ;$$v1993 No 27 pages 14-16
000005706 500__ $$aCanadian Patent Act : amendments to the Canadian Patent Act have struck a major blow against the generic drug manufacturers and have brought Canadian law closer to the GATT ideal;.
000005706 650_0 $$aPatents$$zCanada.
000005706 650_0 $$aIntellectual property$$zCanada.
000005706 650_4 $$aPATENTS : NATIONAL LAW : COMMENTARIES
000005706 650_4 $$aCANADIAN PATENT ACT
000005706 651_0 $$aCanada$$xCommerce$$xLaw and legislation.
000005706 7001_ $$aMcmahon, Eileen.
000005706 830_0 $$aManaging Intellectual Property ;$$v1993 No 27 pages 14-16.
000005706 903__ $$v1$$aMANAGING INTELLECTUAL PROPERTY
000005706 904__ $$aJournal article
000005706 942__ $$cART$$2ddc
000005706 952__ $$w2006-11-03$$p1993-33688$$r0.00$$u6013$$bMAIN$$10$$kGB 72$$v1993-03-27$$zLibrary$$70
000005706 980__ $$aBIB
000005706 999__ $$c5956$$d5956